XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-based Payments and Director Fees (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of management fees and director fees
The following table sets forth the Company’s stock-based management fees and independent director fees ($ in thousands):

Stock-based Management Fees and Director Fees

For the three months ended March 31,
20242023
Number of shares
Amount of expense recognized
Number of shares
Amount of expense recognized
Independent director fees3,080 $15 13,020 $88 
Totals3,080 $15 13,020 $88 
Schedule of grants of restricted stock
Under the Company’s 2014 Director Equity Plan and 2016 Equity Incentive Plan the Company made grants of restricted stock to its Directors and to employees of its Manager and Servicer as set forth in the table below:

Employee and Service Provider GrantsDirector Grants
SharesWeighted Average Grant Date Fair ValueSharesWeighted Average Grant Date Fair Value
Three months ended March 31, 2023
December 31, 2022 outstanding unvested share grants310,262 $10.98 — $— 
Shares vested(30,515)11.56 — — 
Shares forfeited(5,668)10.30 — — 
Shares granted3,000 7.34 25,000 7.15 
March 31, 2023 outstanding unvested share grants277,079 (1)$10.88 25,000 (2)$7.15 
(1)Weighted average remaining life of unvested shares for employee and service provider grants at March 31, 2023 is 2.2 years.
(2)Weighted average remaining life of unvested shares for director grants at March 31, 2023 is 1.9 years.
Employee and Service Provider GrantsDirector Grants
SharesWeighted Average Grant Date Fair ValueSharesWeighted Average Grant Date Fair Value
Three months ended March 31, 2024
December 31, 2023 outstanding unvested share grants159,142 $10.33 25,000 $7.15 
Shares vested(5,625)10.91 — — 
Shares forfeited(2,167)7.89 — — 
Shares granted66,421 3.59 — — 
March 31, 2024 outstanding unvested share grants217,771 (1)$8.29 25,000 (2)$7.15 
(1)Weighted average remaining life of unvested shares for employee and service provider grants at March 31, 2024 is 1.3 years.
(2)Weighted average remaining life of unvested shares for director grants at March 31, 2024 is 0.9 years.
Schedule of restricted stock plan grants, expense
The following table presents the expenses for the Company's restricted stock plan ($ in thousands):

Three months ended March 31,
20242023
Restricted stock grants$253 $517 
Director grants22 
Total expenses for plan grants$275 $524